TRIPLE ANTICOAGULANT THERAPY INCLUDING NOVEL ANTICOAGULANTS (NOACS) AND DUAL ANTIPLATELET THERAPY (DAPT) IS ASSOCIATED WITH SIGNIFICANTLY INCREASED HEMORRHAGE RISK THAN DAPT ALONE

[...]there are no studies evaluating bleeding risk using triple therapy (including NOACs) vs. [...]we sought to evaluate bleeding risk with triple therapy including NOACs vs.

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.546-546
Hauptverfasser:	Pattanshetty, Deepak, Aneja, Ashish
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Cardiology Cardiovascular Health risk assessment Hemorrhage Internal Medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!